Seeing Is Believing
HCAT is currently covered by 16 analysts with an average potential upside of $6.97 (30.11%) from yesterday's end of day stock price of $7.76. Health Catalyst activity chart has currently 65 price targets and 106 ratings on display.
Analysts average stock forecasts to be materialized ratio is 49.39% with an average time for these price targets to be met of 107.69 days.
Highest price target for HCAT is $41, Lowest price target is $6, average price target is $23.5.
Most recent stock forecast was given by JESSICA TASSAN from PIPER SANDLER on 13-Nov-2023. First documented stock forecast 19-Aug-2019.
Currently, out of the existing stock ratings of HCAT - 43 which are a Buy (78.18%), 12 which are a Hold (21.82%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
11
$3.3 (42.86%)
11
25 days ago
2/6 (33.33%)
$6.97 (43.85%)
18
Hold
12
$4.3 (55.84%)
15
1 months 7 days ago
3/7 (42.86%)
$3.88 (24.53%)
57
Hold
8
$0.3 (3.90%)
19
1 months 8 days ago
5/9 (55.56%)
$6 (20.74%)
46
Buy
16
$8.3 (107.79%)
16
2 months 24 days ago
3/6 (50%)
$10.81 (42.57%)
297
Buy
14
$6.3 (81.82%)
16
3 months 9 days ago
3/8 (37.5%)
$6.26 (32.59%)
106
What is HCAT (Health Catalyst) average time for price targets to be met?
Which analyst has the current highest performing score on HCAT (Health Catalyst) with a proven track record?
Which analyst has the most public recommendations on HCAT (Health Catalyst)?
Which analyst is the currently most bullish on HCAT (Health Catalyst)?
Which analyst is the currently most reserved on HCAT (Health Catalyst)?